MarsBio
Overview
MarsBio is a Los Angeles-based venture capital fund that focuses on investing in pre-seed and seed-stage biotech startups, specializing in biosciences and frontier technologies like healthcare, therapeutics, and synthetic biology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aequor Inc. | Dec 2023 | Seed | Co-investor |
| NAPIGEN, INC. | Jul 2022 | Seed | Co-investor |
| Inaru | Feb 2022 | Seed | Co-investor |
| Spout | Jun 2020 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is MarsBio based?
MarsBio is headquartered in Los Angeles, California, United States.
When was MarsBio founded?
MarsBio was founded in 2018.
How many portfolio companies does MarsBio have?
MarsBio has 4 portfolio companies in Caplight's dataset.
What are some companies in MarsBio's portfolio?
Recent investments visible on Caplight include Aequor Inc., NAPIGEN, INC., Inaru, Inaru, Spout.
What was MarsBio's most recent investment?
MarsBio's most recent investment on Caplight was in Aequor Inc. in 2023.
What sectors does MarsBio focus on?
MarsBio focuses on Consumer & Commerce, Consumer & Commerce, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Energy & Sustainability.
What company stages does MarsBio focus on?
MarsBio typically invests at the Early stage.